Frequency and Determinants of Delayed Start of Golimumab Therapy in Psoriatic Arthritis Patients and Impact on Outcomes

Frequency and Determinants of Delayed Start of Golimumab Therapy in Psoriatic Arthritis Patients and Impact on Outcomes | AMiner